Published in Br J Cancer on May 19, 2009
High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer. Br J Cancer (2010) 1.56
The association of Streptococcus bovis/gallolyticus with colorectal tumors: the nature and the underlying mechanisms of its etiological role. J Exp Clin Cancer Res (2011) 1.48
Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion. J Exp Clin Cancer Res (2010) 1.38
The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker. J Transl Med (2010) 1.14
Toll-like receptor 4 activation in cancer progression and therapy. Clin Dev Immunol (2011) 1.14
TLR-4 signalling accelerates colon cancer cell adhesion via NF-κB mediated transcriptional up-regulation of Nox-1. PLoS One (2012) 1.02
The effect of erythropoietin on normal and neoplastic cells. Biologics (2012) 0.98
PKD2 and PKD3 promote prostate cancer cell invasion by modulating NF-κB- and HDAC1-mediated expression and activation of uPA. J Cell Sci (2012) 0.98
Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers. Onco Targets Ther (2013) 0.94
A TLR4-interacting peptide inhibits lipopolysaccharide-stimulated inflammatory responses, migration and invasion of colon cancer SW480 cells. Oncoimmunology (2012) 0.89
The role of toll-like receptors in colorectal cancer progression: evidence for epithelial to leucocytic transition. Front Immunol (2014) 0.86
Activation of Toll-like receptor-9 promotes cellular migration via up-regulating MMP-2 expression in oral squamous cell carcinoma. PLoS One (2014) 0.84
Pattern Recognition Receptors in Cancer Progression and Metastasis. Cancer Growth Metastasis (2015) 0.82
Toll-like receptor 2 (TLR2) induces migration and invasive mechanisms in rheumatoid arthritis. Arthritis Res Ther (2015) 0.80
Multiple roles of toll-like receptor 4 in colorectal cancer. Front Immunol (2014) 0.80
Curcumin suppresses colon cancer cell invasion via AMPK-induced inhibition of NF-κB, uPA activator and MMP9. Oncol Lett (2016) 0.78
Serum Endotoxins and Flagellin and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort. Cancer Epidemiol Biomarkers Prev (2016) 0.78
Toll-like receptors are potential therapeutic targets in rheumatoid arthritis. World J Biol Chem (2011) 0.78
Obesity-associated cancer risk: the role of intestinal microbiota in the etiology of the host proinflammatory state. Transl Res (2016) 0.77
Cotton dust, endotoxin and cancer mortality among the Shanghai textile workers cohort: a 30-year analysis. Occup Environ Med (2013) 0.77
Targeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinoma. Oncotarget (2015) 0.77
Tumor necrosis factor alpha modulates the dynamics of the plasminogen-mediated early interaction between Bifidobacterium animalis subsp. lactis and human enterocytes. Appl Environ Microbiol (2012) 0.76
Effects of TLR4 gene silencing on the proliferation and apotosis of hepatocarcinoma HEPG2 cells. Oncol Lett (2016) 0.76
Surface Toll-Like Receptor 3 Expression in Metastatic Intestinal Epithelial Cells induces Inflammatory Cytokine Production and Promotes Invasiveness. J Biol Chem (2017) 0.75
Inflammation and cancer. Nature (2002) 53.78
Systemic therapy for colorectal cancer. N Engl J Med (2005) 8.94
Structure and function of lipopolysaccharide binding protein. Science (1990) 7.76
Nuclear factor-kappaB: the enemy within. Cancer Cell (2004) 6.86
CYCLOHEXIMIDE: ASPECTS OF INHIBITION OF PROTEIN SYNTHESIS IN MAMMALIAN CELLS. Science (1964) 5.27
Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med (2000) 4.36
Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology (2007) 3.99
Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell (2004) 3.98
A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase. J Cell Biol (1985) 3.62
Regulation of integrin function by the urokinase receptor. Science (1996) 3.56
Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J (1990) 3.27
Biology of tumour metastasis. Lancet (1992) 2.44
The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy. Cancer Metastasis Rev (2003) 2.22
CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression. J Immunol (2001) 1.95
Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO J (1990) 1.87
Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility. J Biol Chem (1998) 1.78
Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin). J Biol Chem (1988) 1.77
Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis. J Natl Cancer Inst (1999) 1.64
Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion. Int J Cancer (2002) 1.57
Urokinase type plasminogen activator receptor expression in colorectal neoplasms. Gut (1998) 1.50
Taxol increases steady-state levels of lipopolysaccharide-inducible genes and protein-tyrosine phosphorylation in murine macrophages. J Immunol (1992) 1.50
Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular matrix components. Cancer Res (1997) 1.49
Urokinase plasminogen activator and its inhibitor, PAI-1, as prognostic markers in breast cancer: from pilot to level 1 evidence studies. Clin Chem (2002) 1.44
The role of endotoxin/lipopolysaccharide in surgically induced tumour growth in a murine model of metastatic disease. Br J Cancer (1999) 1.37
The urokinase receptor is a major vitronectin-binding protein on endothelial cells. Exp Cell Res (1996) 1.34
Endotoxin/lipopolysaccharide activates NF-kappa B and enhances tumor cell adhesion and invasion through a beta 1 integrin-dependent mechanism. J Immunol (2003) 1.31
Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J Biol Chem (1994) 1.30
Responsiveness of intestinal epithelial cell lines to lipopolysaccharide is correlated with Toll-like receptor 4 but not Toll-like receptor 2 or CD14 expression. Int J Colorectal Dis (2002) 1.22
Urokinase receptor and colorectal cancer survival. Lancet (1994) 1.18
The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells. J Biol Chem (1998) 1.17
Urokinase/urokinase receptor and vitronectin/alpha(v)beta(3) integrin induce chemotaxis and cytoskeleton reorganization through different signaling pathways. Oncogene (2001) 1.15
The Jak/Stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells. J Biol Chem (1998) 1.11
Tumor cell adhesion to endothelial cells is increased by endotoxin via an upregulation of beta-1 integrin expression. J Surg Res (2001) 1.06
The effect of laparotomy and laparoscopy on the establishment of spontaneous tumor metastases. Surgery (1998) 1.02
Suppression of rat breast cancer metastasis and reduction of primary tumour growth by the small synthetic urokinase inhibitor WX-UK1. Thromb Haemost (2005) 1.01
Colonic epithelial cell activation and the paradoxical effects of butyrate. Carcinogenesis (1999) 0.98
Inhibition of the invasion capacity of carcinoma cells by WX-UK1, a novel synthetic inhibitor of the urokinase-type plasminogen activator system. Int J Cancer (2004) 0.96
Urokinase-type plasminogen activator in colorectal cancer: relationship with clinicopathological features and patient outcome. Clin Cancer Res (1997) 0.91
Demonstration of urokinase expression in cancer cells of colon adenocarcinomas by immunohistochemistry and in situ hybridization. Am J Pathol (1999) 0.89
Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor. Proc Natl Acad Sci U S A (1990) 0.86
The influence of tumour resection on angiostatin levels and tumour growth--an experimental study in tumour-bearing mice. Eur J Cancer (2001) 0.86
Proteolytic mechanisms operating at the surface of invasive cells. Adv Exp Med Biol (1988) 0.84
The targeting of phosphoinositide-3 kinase attenuates pulmonary metastatic tumor growth following laparotomy. Ann Surg (2006) 0.84
Serum cathepsin B and plasma urokinase-type plasminogen activator levels in gastrointestinal tract cancers. Eur J Cancer Prev (2008) 0.81
Primary liver abscess due to Klebsiella pneumoniae in Taiwan. Clin Infect Dis (1998) 7.51
The Ikaros gene is required for the development of all lymphoid lineages. Cell (1994) 5.90
A brain-specific activator of cyclin-dependent kinase 5. Nature (1994) 2.71
Desmoid tumours. Eur J Surg Oncol (2001) 2.51
Skin and soft-tissue manifestations of Shewanella putrefaciens infection. Clin Infect Dis (1997) 2.45
Extremely high prevalence of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among children in Kaohsiung, Taiwan. J Clin Microbiol (1998) 2.24
Mechanism of activation of a cyclic adenosine 3':5'-monophosphate phosphodiesterase from bovine heart by calcium ions. Identification of the protein activator as a Ca2+ binding protein. J Biol Chem (1973) 2.12
Excisional surgery for cancer cure: therapy at a cost. Lancet Oncol (2003) 2.09
A dimeric crystal structure for the N-terminal two domains of intercellular adhesion molecule-1. Proc Natl Acad Sci U S A (1998) 1.91
Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction. Nat Neurosci (2001) 1.86
Provider volume and outcomes for oncological procedures. Br J Surg (2005) 1.83
Pre-T cell receptor (TCR) and TCR-controlled checkpoints in T cell differentiation are set by Ikaros. J Exp Med (1999) 1.82
Modulator binding protein. Bovine brain protein exhibiting the Ca2+-dependent association with the protein modulator of cyclic nucleotide phosphodiesterase. J Biol Chem (1977) 1.79
Neutrophils undergo apoptosis following ingestion of Escherichia coli. J Immunol (1996) 1.74
Effects of a selective cyclo-oxygenase 2 inhibitor on colonic anastomotic and skin wound integrity. Br J Surg (2004) 1.68
Calmodulin and its role in the second-messenger system. Curr Top Cell Regul (1979) 1.67
Purification and properties of the protein activator of bovine heart cyclic adenosine 3',5'-monophosphate phosphodiesterase. J Biol Chem (1973) 1.67
Exposure of the peritoneal cavity to air regulates early inflammatory responses to surgery in a murine model. Br J Surg (1995) 1.67
Plasma nitric oxide levels in newborn infants with sepsis. J Pediatr (1993) 1.66
Vascular trauma--a review. J Am Coll Surg (1995) 1.64
Preparation and assay of the Ca2+--dependent modulator protein. Adv Cyclic Nucleotide Res (1979) 1.63
TGF beta-1 regulation of VEGF production by breast cancer cells. Ann Surg Oncol (1997) 1.63
Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China. Bull World Health Organ (2001) 1.63
An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator. J Biol Chem (1995) 1.60
Metastatic manifestations of invasive lobular breast carcinoma. Clin Radiol (2005) 1.59
Solubilization of a specific tetrodotoxin-binding component from garfish olfactory nerve membrane. Biochemistry (1972) 1.56
Failure of macrophage activation in experimental obstructive jaundice: association with bacterial translocation. Br J Surg (1995) 1.55
Video-assisted thoracoscopic T2 sympathectomy for hyperhidrosis palmaris. J Am Coll Surg (1994) 1.54
Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIII. Blood (1993) 1.53
Sodium hyaluronate enhances colorectal tumour cell metastatic potential in vitro and in vivo. Br J Surg (2001) 1.53
What a signature adds to the consent process. Surg Endosc (2008) 1.53
Clinical features of convulsive status epilepticus: a study of 220 cases in western China. Eur J Neurol (2009) 1.53
Sequential changes in heart rate variability after coronary artery bypass grafting. Am J Cardiol (1999) 1.51
Structural basis of CD8 coreceptor function revealed by crystallographic analysis of a murine CD8alphaalpha ectodomain fragment in complex with H-2Kb. Immunity (1998) 1.51
Hypertonic saline attenuates end-organ damage in an experimental model of acute pancreatitis. Br J Surg (2000) 1.51
Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments. J Biol Chem (1993) 1.50
Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor beta-1. Ann Surg Oncol (1998) 1.49
A synthetic peptide derived from p34cdc2 is a specific and efficient substrate of src-family tyrosine kinases. J Biol Chem (1992) 1.46
Sentinel lymph node biopsy: is it possible to reduce false negative rates by excluding patients with nodular melanoma? Surgeon (2006) 1.46
Cloning of three novel neuronal Cdk5 activator binding proteins. Gene (2000) 1.44
Perioperative topical nitrate and sphincter function in patients undergoing transanal stapled anastomosis: a randomized, placebo-controlled, double-blinded trial. Dis Colon Rectum (2004) 1.44
Attenuation of pancreatitis-induced pulmonary injury by aerosolized hypertonic saline. Surg Infect (Larchmt) (2001) 1.44
CT-guided percutaneous neurolytic celiac plexus block technique. Abdom Imaging (2007) 1.43
Laparoscopic-assisted appendicectomy (LAA): a novel advance on an established procedure. Endoscopy (2001) 1.40
Co-firing coal with rice husk and bamboo and the impact on particulate matters and associated polycyclic aromatic hydrocarbon emissions. Bioresour Technol (2007) 1.40
Spontaneous aortic aneurysms in blotchy mice. Am J Pathol (1975) 1.40
Daily diurnal variation in admissions for ruptured abdominal aortic aneurysms. World J Surg (2007) 1.39
Rapid on-site evaluation of axillary fine-needle aspiration cytology in breast cancer. Br J Surg (2012) 1.39
Sentinel lymph node mapping in colorectal cancer (Br J Surg 2003; 90: 659-67 [corrected]). Br J Surg (2003) 1.38
Comparison of calcium-binding proteins. Bovine heart and brain protein activators of cyclic nucleotide phosphodiesterase and rabbit skeletal muscle troponin C. J Biol Chem (1976) 1.38
Changes in intrahepatic portal hemodynamic in early stage hepatic abscesses. J Ultrasound Med (1996) 1.38
Brain proline-directed protein kinase is a neurofilament kinase which displays high sequence homology to p34cdc2. J Biol Chem (1992) 1.37
The role of endotoxin/lipopolysaccharide in surgically induced tumour growth in a murine model of metastatic disease. Br J Cancer (1999) 1.37
Protein phosphatase 2A is the major enzyme in brain that dephosphorylates tau protein phosphorylated by proline-directed protein kinases or cyclic AMP-dependent protein kinase. J Neurochem (1995) 1.36
Is human fracture hematoma inherently angiogenic? Clin Orthop Relat Res (2000) 1.36
Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells. Cell Death Differ (2004) 1.34
Crystal structure of ICAM-2 reveals a distinctive integrin recognition surface. Nature (1997) 1.34
Different excitation and reception distributions with a single-loop transmit-receive surface coil near a head-sized spherical phantom at 300 MHz. Magn Reson Med (2002) 1.34
Facilitated proton transfer in enzyme catalysis. It may have a crucial role in determining the efficiency and specificity of enzymes. Science (1968) 1.33
Purification and properties of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase. J Biol Chem (1980) 1.31
Purification and characterization of a novel proline-directed protein kinase from bovine brain. J Biol Chem (1992) 1.30
Human neutrophils facilitate tumor cell transendothelial migration. Am J Physiol Cell Physiol (2001) 1.29
2 A crystal structure of an extracellular fragment of human CD40 ligand. Structure (1995) 1.29
Purification of the heat-stable inhibitor protein of the Ca2+-activated cyclic nucleotide phosphodiesterase by affinity chromatography. Can J Biochem (1978) 1.29
Tissue engineering of ligament and tendon healing. Clin Orthop Relat Res (1999) 1.28
Calmodulin-stimulated dephosphorylation of p-nitrophenyl phosphate and free phosphotyrosine by calcineurin. J Biol Chem (1983) 1.27
p34cdc2 kinase is localized to distinct domains within the mitotic apparatus. Cell Motil Cytoskeleton (1990) 1.26
Trichobezoar. J R Soc Med (2001) 1.25
Purification and subunit structure of bovine brain modulator binding protein. J Biol Chem (1979) 1.24
Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword? Br J Cancer (2006) 1.23
Mycotic aneurysm due to Burkholderia pseudomallei. Clin Infect Dis (1998) 1.23
Neuronal cdc2-like kinase. Trends Biochem Sci (1995) 1.21
Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem (1997) 1.19
Mycotic aneurysm due to non-typhi salmonella: report of 16 cases. Clin Infect Dis (1996) 1.19
Haemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular patients. Is HbA1C an independent risk factor and predictor of adverse outcome? Eur J Vasc Endovasc Surg (2006) 1.18
Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection. Cancer (1999) 1.17
The modulator-dependent protein kinase. A multifunctional protein kinase activatable by the Ca2+-dependent modulator protein of the cyclic nucleotide system. J Biol Chem (1978) 1.17
Use of fluorinated tyrosine phosphates to probe the substrate specificity of the low molecular weight phosphatase activity of calcineurin. J Biol Chem (1985) 1.16
Host defense--a role for the amino acid taurine? JPEN J Parenter Enteral Nutr (1998) 1.16
Dependence of cardiac sarcoplasmic reticulum calcium pump activity on the phosphorylation status of phospholamban. J Biol Chem (1991) 1.15
Postextubation laryngeal edema in adults. Risk factor evaluation and prevention by hydrocortisone. Intensive Care Med (1996) 1.15
The binding of 35S-labeled recombinant factor VIII to activated and unactivated human platelets. J Biol Chem (1988) 1.15
Sulfate-reducing bacteria colonize pouches formed for ulcerative colitis but not for familial adenomatous polyposis. Dis Colon Rectum (2002) 1.15
Purification of a Ca2+-activatable cyclic nucleotide phosphodiesterase from bovine heart by specific interaction with its Ca2+-dependent modulator protein. J Biol Chem (1977) 1.14
Hepatic potential of bone marrow stromal cells: development of in vitro co-culture and intra-portal transplantation models. J Immunol Methods (2005) 1.14
Massive retroperitoneal ganglioneuroma presenting with small bowel obstruction 18 years following initial diagnosis. Ir J Med Sci (2005) 1.14
The distribution of the Ca++-dependent protein activator of cyclic nucleotide phosphodiesterase in invertebrates. Biochem Biophys Res Commun (1975) 1.13
Conversion of light to chemical free energy. I. Porphyrin-sensitized photoreduction of ferredoxin by glutathione. J Biol Chem (1969) 1.13
Mechanism of activation of cyclic nucleotide phosphodiesterase: requirement of the binding of four Ca2+ to calmodulin for activation. Proc Natl Acad Sci U S A (1981) 1.13
Taurine prevents high-glucose-induced human vascular endothelial cell apoptosis. Am J Physiol (1999) 1.11